Designated Filer:
|
Monarch Alternative Capital LP
|
Issuer & Ticker Symbol:
|
Resolute Energy Corp. [REN]
|
Date of Event Requiring Statement:
|
May 15, 2018
|
(1)
|
This Form 3 is being filed on behalf of Monarch Alternative Capital LP, a Delaware limited partnership (“MAC”), MDRA GP LP, a Delaware limited partnership (“MDRA GP”), and Monarch GP LLC, a Delaware limited liability company (“Monarch GP” and, together with MAC and MDRA GP, the “Reporting Persons”). MAC serves as the investment advisor to the Funds (as defined below). MDRA GP is the general partner of MAC and Monarch GP is the general partner of MDRA GP. Each of MAC, MDRA GP and Monarch GP may be deemed to indirectly beneficially own shares held directly by the Funds and disclaims beneficial ownership of all such shares except to the extent of any indirect pecuniary interest therein.
|
(2)
|
Common Stock held by Monarch Alternative Solutions Master Fund Ltd, a Cayman Islands corporation (“MASMF”).
|
(3)
|
Common Stock held by Monarch Capital Master Partners III LP, a Cayman Islands limited partnership (“MCMP III”).
|
(4)
|
Common Stock held by MCP Holdings Master LP, a Cayman Islands limited partnership (“MCPH”).
|
(5)
|
Common Stock held by Monarch Debt Recovery Master Fund Ltd, a Cayman Islands corporation (“MDRF”).
|
(6)
|
Common Stock held by Monarch Capital Master Partners IV LP, a Cayman Islands limited partnership (“MCMP IV”).
|
(7)
|
Common Stock held by P Monarch Recovery Ltd., a British Virgin Islands corporation (“PMR” and, together with MASMF, MCMP III, MCPH, MDRF and MCMP IV, the “Funds”).
|
Designated Filer:
|
Monarch Alternative Capital LP
|
Issuer & Ticker Symbol:
|
Resolute Energy Corp. [REN]
|
Date of Event Requiring Statement:
|
May 15, 2018
|
|
|
|
|
|
|
|
|
1.
|
Name:
|
MDRA GP LP
|
|||||
|
Address:
|
c/o Monarch Alternative Capital LP, 535 Madison Avenue, New York, New York 10022
|
|||||
|
|
|
|
|
|||
|
|
MDRA GP LP
|
|||||
|
|
|
|
|
|||
|
|
By: Monarch GP LLC, its general partner
|
|||||
|
|
|
|
|
|
||
|
|
By: /s/ Michael Weinstock
|
|
May 17, 2018
|
|||
|
|
Name:
|
Michael Weinstock
|
|
Date
|
||
|
|
Title:
|
Chief Executive Officer
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
2.
|
Name:
|
Monarch GP LLC
|
|||||
|
Address:
|
c/o Monarch Alternative Capital LP, 535 Madison Avenue, New York, New York 10022
|
|||||
|
|
|
|
|
|||
|
|
MONARCH GP LLC
|
|||||
|
|
|
|
|
|
||
|
|
By:/s/ Michael Weinstock
|
|
May 17, 2018
|
|||
|
|
Name:
|
Michael Weinstock
|
|
Date
|
||
|
|
Title:
|
Chief Executive Officer
|
|
|
||
|
|
|
|
|
|
|
|